Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAX-114 in adults with essential tremor
NCT05387642Phase 2Withdrawn
- Sponsor
- Praxis Precision Medicines
- Start
- Apr 2022
- Primary completion
- Jun 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of PRAX-114 in essential tremor (ET), sponsored by Praxis Precision Medicines. Planned start Apr 2022; status: withdrawn.
02
Drugs
PRAX-114
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT05387642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05387642.